Sarah Mirzaie

Sarah Mirzaie

Auto-generated profile, based on publicly available information

Sarah Mirzaie

Division of Plastic & Reconstructive Surgery University of California Los Angeles David Geffen School of Medicine Los Angeles CA 90095 USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2019 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
SASahar Alimirzaie
Sahar Alimirzaie
MBMaryam Bagherzadeh
Maryam Bagherzadeh
Mohammad Reza AkbariMohammad Reza Akbari
Mohammad Reza Akbari

15 November 2024 in Advanced Therapeutics
Verified
Journal Article
Open access
KSKaavian Shariati
Kaavian Shariati
MBMeiwand Bedar
Meiwand Bedar
KHKelly Huang
Kelly Huang
SMShahrzad Moghadam
Shahrzad Moghadam
SMSarah Mirzaie
Sarah Mirzaie
JLJustine C. Lee
Justine C. Lee
Tissue regeneration involves dynamic dialogue between and among different cells and their surrounding matrices. Bone regeneration is specifically governed by reciprocity between osteoblasts and osteoclasts within the bone microenvironment. Osteoclast‐directed resorption and osteoblast‐directed formation of bone are essential to bone remodeling, and the crosstalk between these cells is vital to curating a sequence of events that culminate in the creation of bone tissue. Among bone biomaterial strategies, many have investigated the use of different material cues to direct the development and activity of osteoblasts. However, less attention has been given to exploring features that similarly target osteoclast formation and activity, with even fewer strategies demonstrating or integrating biomaterial‐directed modulation of osteoblast‐osteoclast coupling. This review aims to describe various biomaterial cues demonstrated to influence osteoclastogenesis and osteoclast function, emphasizing those that enhance a material construct's ability to achieve bone healing and regeneration. Additionally discussed are approaches that influence the communication between osteoclasts and osteoblasts, particularly in a manner that takes advantage of their coupling. Deepening the understanding of how biomaterial cues may dictate osteoclast differentiation, function, and influence on the microenvironment may enable the realization of bone‐replacement interventions with enhanced integrative and regenerative capacities.

1 June 2018
Verified
Journal Article
Closed access
SASahar Alimirzaie
Sahar Alimirzaie
AMAshraf Mohamadkhani
Ashraf Mohamadkhani
SMSahar Masoudi
Sahar Masoudi
ESErin Sellars
Erin Sellars
PBPaolo Boffetta
Paolo Boffetta
APAkram Pourshams
Akram Pourshams

8 August 2023 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
PDF file
SMSarah Mirzaie
Sarah Mirzaie
JPJoon Y. Park
Joon Y. Park
MMMichael A. Mederos
Michael A. Mederos
MGMark D. Girgis
Mark D. Girgis
Background Duodenal neuroendocrine tumors (dNETs) are rare, and their management is not well-defined. National Comprehensive Cancer Network (NCCN) guidelines recommend surgical resection of large dNETs (> 2 cm) and endoscopic resection of small tumors (< 2 cm). We compared the survival outcomes between surgical and endoscopic resection in various dNET sizes. Methods A retrospective cohort study was conducted using patient data from Surveillance, Epidemiology, and End Results Program (SEER) database. Variables analyzed included age, tumor size, grade, stage, and lymph node status. Disease-specific survival (DSS) was compared for endoscopic and surgical groups in dNET size strata: 0–0.5, 0.5–1, 1–2, 2–3, and > 3 cm. Kaplan–Meier and multivariable Cox proportional hazards models were used for survival analysis. Results The study included 465 patients, with 124 (26.7%) undergoing surgical resection. The average age was 61.9 years, and tumor sizes ranged from 0.1 to 10.5 cm. Endoscopic resection had 40.5% of tumors between 0 and 0.5 cm, while surgery had only 21% (p < 0.001). In the surgical cohort, 79.8% had grade 1 tumors compared to 88.3% in the endoscopy group (P = 0.024). Among surgically resected cases, 48.4% (60 patients) had lymph node involvement. Age, tumor size, grade, and stage did not significantly predict survival after surgical resection. Stratified by tumor size, no difference in DSS was observed between surgery and endoscopy groups. Conclusions Endoscopic resection demonstrated similar survival outcomes to surgical resection across dNET sizes in this national analysis. Given the risks and the lack of survival benefits for surgery, endoscopic resection may be beneficial for both small and large tumors. Further studies are warranted to validate the current NCCN guidelines.

6 June 2023 in The American Surgeon™
Verified
Journal Article
Open access
JPJoon Y. Park
Joon Y. Park
SMSarah Mirzaie
Sarah Mirzaie
APAly Premji
Aly Premji
YSYoungji Seo
Youngji Seo
MMMichael Mederos
Michael Mederos
MGMark Girgis
Mark Girgis
Introduction: Robotic pancreaticoduodenectomy (rPD) is a complex operation with a reported learning curve of 80 cases. Two recent graduates of a formal robotic complex general surgical oncology training program have been performing rPD at our institution since 2016, which had no previous institutional experience with rPD. Objective: To evaluate the learning curve associated with developing a new robotic pancreaticoduodenectomy (rPD) program by fellowship trained surgeons with institutional support. Methods: Sixty patients undergoing rPD from 2016 to 2022 were reviewed for and compared with proficiency benchmarks set by the University of Pittsburg experience. Results: By 30 cases, operative time met the proficiency benchmark of 391 minutes. Additionally, the entire cohort had comparable rates of clinically relevant postoperative pancreatic fistula (6.7% vs 3%, P = .6), 30-day mortality (0% vs 3%, P = .18), major complications (Clavien >2; 23% vs 17%, P = .14), and length of stay (6 vs 7 days, P = .49) when compared to the benchmark. Conclusion: Perioperative outcomes were comparable to proficiency benchmarks from initiation of the new rPD program, and operative time reached proficiency benchmark by 30 cases. This data suggests that graduates of formal rPD training programs can safely establish new minimally invasive pancreas programs at sites with no previous institutional rPD experience.

1 April 2023 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
SMSarah Mirzaie
Sarah Mirzaie
THTheodore X. Hu
Theodore X. Hu
LYLu Yang
Lu Yang
KLKaty L. Lawson
Katy L. Lawson
MGMark D. Girgis
Mark D. Girgis
Introduction and importance: Heterotopic Pancreas (HP) is defined by the presence of pancreatic tissue in an anatomically distinct location from the main pancreas. While often clinically silent, it may present symptomatically. If located in the gastric antrum, HP may cause gastric outlet obstruction (GOO). The objective of this paper is to present a rare case of HP in the gastric antrum causing GOO. Case presentation: Herein, we report a 43-year-old man who presented with abdominal pain and non-bilious emesis in the setting of COVID-19 infection and alcohol consumption. During the initial workup, computed-tomography (CT) was non-specific but demonstrated GOO, concerning for cancer. Cold forceps biopsies taken during esophagogastroduodenoscopy (EGD) confirmed benign HP. Since the patient was symptomatic from gastric outlet compression, he underwent resection via laparoscopic distal gastrectomy and Billroth II gastrojejunostomy. At 1-month postoperative follow-up, the patient recovered uneventfully. We hypothesized that GOO by HP in this case may have been associated with cumulative effects of alcohol consumption and COVID-19 infection on the ectopic tissue. Clinical discussion: HP is rare and difficult to diagnose preoperatively. When located in gastric antrum, HP can cause GOO, mimicking gastric malignancy. Combination of EGD/EUS, biopsy/FNA, and surgical resection are necessary to definitively make the diagnosis. Finally, it is important to consider that heterotopic pancreatitis or structural changes in HP may occur due to classic pancreatic stressors like alcohol and viral infections. Conclusion: HP may cause GOO presenting with non-bilious emesis and abdominal pain, mistaken for malignancy on CT imaging. Highlights: